The efficacy of intranasal oxytocin before applied behavior analysis (ABA) therapy with autistic spectrum disorder

The efficacy of intranasal oxytocin before applied behavior analysis (ABA) therapy of youth (4-17 years old) with autistic spectrum disorder

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20211004052670N1

Enrollment

Registered

2021-12-28

Start date

2022-01-15

Completion date

Unknown

Last updated

2022-01-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autism. Autistic disorder

Interventions

Intervention 1: Intervention group: In this group, patients have been prescribed three puffs of oxytocin spray in each nostril (4 IU per puff). Before the spray and half an hour after the end of the s

Eligibility

Sex/Gender

All

Age

4 Years to 17 Years

Inclusion criteria

Inclusion criteria: autism 4-17 year old

Exclusion criteria

Exclusion criteria: endocrine disease head thruma neurologic problem

Design outcomes

Primary

Measure	Time frame
Severity of autism. Timepoint: Before the intervention, the sixth week during the intervention and 6 weeks after the intervention. Method of measurement: Gilliam Autism Rating Scale (GARS).;Strenght and Difficulties. Timepoint: Before the intervention, the sixth week during the intervention and 6 weeks after the intervention. Method of measurement: Strengths and Difficulties Questionnaire (SDQ).	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSafie Shafiezadegan-Isfahani

Esfahan University of Medical Sciences

ss.shafiezadegan70@gmail.com+98 31 3662 5950

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026